Search results for: “keytruda”
-
Blog
Drew Griffin’s Immunotherapy Story
Colorectal Cancer | Diagnosed 2012 Be the change you seek in the world. Drew’s Story In October 2012,… -
Blog
International HPV Awareness Day and the Importance of Immunotherapy
Immunotherapy is crucial to efforts to prevent HPV infection and treat patients with HPV-associated cancers.
-
Blog
Stomach Cancer Awareness Month: 2019 Immunotherapy Research Update
We round up the latest immunotherapy for stomach cancer news and research from the scientists, physicians, and…
-
Blog
Lung Cancer Awareness Month: 2019 Immunotherapy Research Update
We round up the latest news and research from the people changing the future of lung cancer…
-
Blog
Cancer Research Institute Returns to Houston with an Immunotherapy Patient Summit for Third Time
On October 26, 2019, CRI hosted an Immunotherapy Patient Summit at MD Anderson Cancer Center for 120…
-
Blog
A Powerful Community of Patients, Caregivers, and Advocates Gather at the Cancer Research Institute Immunotherapy Patient Summit in New York City
On Saturday, September 7, 2019, over 275 patients, survivors, caregivers, advocates, and healthcare professionals attended the CRI…
-
Blog
Curtis Garbett’s Immunotherapy Story
Bladder Cancer | Diagnosed 2015 Advancing cancer research and visioning a future immune to bladder cancer Curtis’s Story… -
Blog
FDA Approves Pembrolizumab Immunotherapy for Advanced Liver Cancer
Patients with advanced hepatocellular carcinoma (HCC), the most common form of liver cancer, can now receive PD-1…
-
Blog
First Checkpoint Immunotherapy Approved for Advanced Cervical Cancer
Pembrolizumab, a PD-1-targeting immunotherapy, was approved for recurrent advanced cervical cancer that expresses PD-L1.